Floatz logo

Therapeutic Asset Ratings

615 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Shr-1167
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Shr-1701
Metastatic Malignant Neoplasm In The Colon
Fudan UniversityP2CCC (48)
shr2554
Metastatic Malignant Neoplasm In The Colon
Fudan UniversityP2CCC (48)
Shr-4602
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Shr-4602
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Shr-6209
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Shr-A1811
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Shr-A1921
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Shr-A1921
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Shr-A2009
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Shr-A2102
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Sorafenib
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
TAMOXIFEN
Pancreatic Cancer
Fudan UniversityP2CCC (48)
tqb2102
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
tqb2868
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
tqb2868
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Cyclophosphamide
Parsaclisib
Fudan UniversityP1/2CCC (48)
Cyclophosphamide
PI3Kδ Inhibitor
Fudan UniversityP1/2CCC (48)
Golidocitinib
Lymphoma
Fudan UniversityP1/2CCC (48)
Inno-206
Parsaclisib
Fudan UniversityP1/2CCC (48)
Inno-206
PI3Kδ Inhibitor
Fudan UniversityP1/2CCC (48)
Parsaclisib
Cognitive Impairment - Coarse Facies - Heart Defects - Obesity - Pulmonary Involvement - Short Stature - Skeletal Dysplasia Syndrome
Fudan UniversityP1/2CCC (48)
Parsaclisib
Parsaclisib
Fudan UniversityP1/2CCC (48)
Parsaclisib
PI3Kδ Inhibitor
Fudan UniversityP1/2CCC (48)
PREDNISONE TABLETS
Parsaclisib
Fudan UniversityP1/2CCC (48)
Showing 501 to 525 of 615 assets
PreviousPage 21 of 25Next